Dr Lynsey McKenzie Hasan Issa Sandeep Potluri Dr Helen Blair Asmida Isa et al. | The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation | 2018 |
|
Dr Victoria Forster Alex McDonnell Dr Jill McKay
| Effect of methotrexate/Vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity | 2017 |
|
Dr Victoria Forster Dr Frederik van Delft Professor Roderick Skinner
| Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect | 2017 |
|
Dr Victoria Forster Mohammed Nahari Dr Natalia Martinez Soria Amy Bradburn Dr Sarah Fordham et al. | The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype | 2016 |
|
Judith Weiland Dr Alex Elder Dr Victoria Forster Professor Olaf Heidenreich Professor Hermann Josef Vormoor et al. | CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia | 2015 |
|
Dr Victoria Forster Mohammed Nahari Dr Natalia Martinez Soria Amy Bradburn Hesta McNeill et al. | The Leukemia-Associated RUNX1/ETO Oncoprotein Confers a Mutator Phenotype | 2015 |
|
Dr Sarah Fordham Dr Victoria Forster Professor Graham Jackson Dr Simon Bomken Professor James Allan et al. | A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia | 2012 |
|
Dr Victoria Forster Dr Andrea Beyerle Professor Olaf Heidenreich Professor James Allan
| AML1/ETO Confers a Mutator Phenotype In Acute Myeloid Leukemia Associated with Downregulation of the Base-Excision-Repair Gene OGG1 | 2011 |
|
Dr Victoria Forster Amy Bradburn Professor James Allan Professor Olaf Heidenreich
| The Angiogenic Factor Angiopoietin-1 Is Regulated by the Acute Myeloid Leukemia Fusion Protein AML1/ETO | 2011 |
|
Dr Victoria Forster Professor James Allan Professor Olaf Heidenreich
| The t(8,21) Fusion Protein AML1/ETO Promotes Susceptibility to Mutation In Acute Myeloid Leukemia | 2010 |
|
Dr Victoria Forster Professor James Allan Professor Olaf Heidenreich
| The t(8;21) Fusion Protein AML1/ETO Promotes Susceptibility to Mutation In Acute Myeloid Leukemia | 2010 |
|